Stocks and InvestingStocks and Investing
Wed, May 19, 2021
Tue, May 18, 2021
Mon, May 17, 2021
Fri, May 14, 2021
Thu, May 13, 2021

Anupam Rama Upgraded (ATRA) to Buy and Increased Target to $725 on, May 13th, 2021


Published on 2024-10-27 16:40:29 - WOPRAI, Anupam Rama
  Print publication without navigation


Anupam Rama of JP Morgan, Upgraded "Atara Biotherapeutics, Inc." (ATRA) to Buy and Increased Target from $575 to $725 on, May 13th, 2021.

Anupam has made no other calls on ATRA in the last 4 months.



There is 1 other peer that has a rating on ATRA. Out of the 1 peers that are also analyzing ATRA, 0 agree with Anupam's Rating of Hold.



This is the rating of the analyst that currently disagrees with Anupam


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $775 on, Wednesday, May 5th, 2021